Efficacy and tolerability of levetiracetam in children with epilepsy

Brain and Development

Volumn 33, Issue 2, 2011, Pages 145-151

  Li, Jiahui ^a   Xiao, Nong ^a   Chen, Siyuan ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Efficacy; Epilepsy; Levetiracetam; Retention rates; Side effects

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; LAMOTRIGINE; NITRAZEPAM; OXCARBAZEPINE; TOPIRAMATE; VALPROIC ACID;

AGGRESSION; ARTICLE; CHILD; CLINICAL ASSESSMENT; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHORIA; DYSTROPHY; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NERVOUSNESS; OPEN STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SIDE EFFECT; SLEEP DISORDER; SOMNIPATHY; SOMNOLENCE; TREATMENT DURATION;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; PIRACETAM; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 78751604631     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2010.03.002     Document Type: Article

References (29)

1. Gilman J.T., Duchowny M., Campo A.E. Pharmacokinetic considerations in the treatment of childhood epilepsy. Pediatr Drugs 2003, 5:267-277.
2. Patsalos P.N. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 2000, 85:77-85.
3. Perucca E., Gidal B.E., Baltes E. Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials. Epilepsy Res 2003, 53:47-56.
4. Glauser T.A., Ayala R., Elterman R.D., Mitchell W.G., Van Orman C.B., Gauer L.J., et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006, 66:1654-1660. N159 Study Group.
5. UCB/N166 Study. Levetiracetam as add-on treatment of myoclonic jerks in adolescents and adults. ClinicalTrials.gov. Available from: http://clinicaltrials.gov/show/NCT00150774.
6. Ben-Menachem E., Falter U. Efficacy and tolerability of levetiracetam 3000mg/d in patients with refractory focal seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000, 41:1276-1283. European Levetiracetam Study Group.
7. Cereghino J.J., Biton V., Abou-Khalil B., Dreifuss F., Gauer L.J., Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000, 55:236-242. United States Levetiracetam Study Group.
8. Shorvon S.D., Lowenthal A., Janz D., Bielen E., Loiseau P. Multicenter, doubleblind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia 2000, 41:1179-1186. European Levetiracetam Study Group.
9. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981, 22:489-501. Commission of Classification and Terminology of the International League Against Epilepsy.
10. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399. Commission of Classification and Terminology of the International League Against Epilepsy.
11. Hauser W.A., Annegers J.F., Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-84. Epilepsia 1993, 34:453-468.
12. Hauser W.A., Annegers J.F., Kurland L.T. Prevalence of epilepsy in Rochester, Minnesota: 1940-80. Epilepsia 1991, 32:429-445.
13. Reynolds E.H. ILAE{minus 45 degree rule}IBE{minus 45 degree rule}WHO Global Campaign "Out of the Shadows'': global and regional developments. Epilepsia 2001, 42:1094-1100.
14. Scot R.A., Lhatoo S.D., Sander J.W. The treatment of epilepsy in developing countries: where do we go from here?. Bull World Health Organ 2001, 79:344-351.
15. Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 2004, 3:618-621.
16. Ben-Menachem E., Falter U. Efficacy and tolerability of levetiracetam 3000mg/day in patients with refractory partial seizures: a multicentre, double-blind, responder selected study evaluating monotherapy. Epilepsia 2000, 41:1276-1283.
17. Grunewald R. Levetiracetam in the treatment of idiopathic generalized epilepsies. Epilepsia 2005, 46:154-160.
18. Hermann S., Wang-Tilz Y., Pauli E., Dennhofer S., Genow A., Kerling F., et al. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA). Epilepsia 2006, 47:516-522.
19. Abou-Khalil B. Levetiracetam in the treatment of epilepsy. Neuropsychiatr Dis Treat 2008, 4:507-523.
20. A receptors upon repetitive activation. Epilepsia 2007, 48:1842-1849.
21. Perry M.S., Benatar M. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review. Epilepsia 2007, 48:1123-1127.
22. Grosso S., Cordelli D.M., Franzoni E., Coppola G., Capovilla G., Zamponi N., et al. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy. Seizure 2007, 16:345-350.
23. Hirsch L.J., Arif H., Buchsbaum R., Weintraub D., Lee J., Chang J.T., et al. Effect of age and comedication on Levetiracetam pharmacokineties and tolerability. Epilepsia 2007, 48:1351-1359.
24. Sharpe D.V., Patel A.D., Abou-Khalil B., Fenichel G. Levetiracetam monotherapy in juvenile myoclonic epilepsy. Seizure 2008, 17:64-68.
25. Weintraub D., Buchsbaum R., Resor S.R., Hirsch L.J. Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Epilepsy Behav 2007, 10:105-110.
26. Glanser T.A., Ayala R., Elterman R.D., Mitchell W.G., Van Orman C.B., Gauer L.J., et al. Double blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006, 66:l654-1660.
27. Stefan H., Feuerstein T.J. Novel anticonvulsant drugs. Pharmacol Ther 2007, 113(1):165-183.
28. Macleod S., Appleton R.E. The new antiepileptic drugs. Arch Dis Child Educ Pract Ed 2007, 92:182-188.
29. Depondt C., Yuen A.W., Bell G.S., Mitchell T., Koepp M.J., Duncan J.S., et al. The long term retention of levetiracetam in a large cohort of patients with epilepsy. Neurol Neurosurg Psychiatry 2006, 77:10-13.